- Home
- MAMK vs SNTI Comparison
MAMK vs SNTI Comparison
Compare MAMK & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMK
- SNTI
- Stock Information
- Founded
- MAMK 2007
- SNTI 2016
- Country
- MAMK China
- SNTI United States
- Employees
- MAMK N/A
- SNTI N/A
- Industry
- MAMK Apparel
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- MAMK Consumer Discretionary
- SNTI Health Care
- Exchange
- MAMK Nasdaq
- SNTI Nasdaq
- Market Cap
- MAMK 43.2M
- SNTI 39.6M
- IPO Year
- MAMK 2025
- SNTI N/A
- Fundamental
- Price
- MAMK N/A
- SNTI $1.78
- Analyst Decision
- MAMK
- SNTI Strong Buy
- Analyst Count
- MAMK 0
- SNTI 2
- Target Price
- MAMK N/A
- SNTI $8.50
- AVG Volume (30 Days)
- MAMK 103.4K
- SNTI 139.1K
- Earning Date
- MAMK 01-01-0001
- SNTI 11-13-2025
- Dividend Yield
- MAMK N/A
- SNTI N/A
- EPS Growth
- MAMK N/A
- SNTI N/A
- EPS
- MAMK 0.12
- SNTI N/A
- Revenue
- MAMK $21,434,100.00
- SNTI N/A
- Revenue This Year
- MAMK N/A
- SNTI N/A
- Revenue Next Year
- MAMK N/A
- SNTI $150.00
- P/E Ratio
- MAMK $23.16
- SNTI N/A
- Revenue Growth
- MAMK N/A
- SNTI N/A
- 52 Week Low
- MAMK $1.87
- SNTI $1.26
- 52 Week High
- MAMK $4.00
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- MAMK N/A
- SNTI 73.44
- Support Level
- MAMK N/A
- SNTI $1.36
- Resistance Level
- MAMK N/A
- SNTI $1.75
- Average True Range (ATR)
- MAMK 0.00
- SNTI 0.08
- MACD
- MAMK 0.00
- SNTI 0.05
- Stochastic Oscillator
- MAMK 0.00
- SNTI 95.45
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.